MedTrace Logo

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer

NCT03711890 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-03-30

No results posted yet for this study

Summary

This trial studies how well ultra-high resolution optical coherence tomography works in detecting micrometer sized early stage pancreatic cancer in participants with pancreatic cancer. Ultra-high resolution optical coherence tomography may help to accurately identify pancreatic cancer in resected pancreatic specimens.

Conditions

  • Pancreatic Carcinoma
  • Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type

Interventions

PROCEDURE

Optical Coherence Tomography

Undergo OCT

PROCEDURE

Therapeutic Conventional Surgery

Undergo resection will be undertaken

DIAGNOSTIC_TEST

Laboratory Evaluation

Labs will be obtained to test for cancer cell derived exosomes

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Mary Dillhoff, MD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-26
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03711890 on ClinicalTrials.gov